Table 2.
Laboratory data of patients and controls groups.
| Patients (N = 50) | Controls (N = 50) | P value | |||
|---|---|---|---|---|---|
| Range | Mean ± SD | Range | Mean ± SD | ||
| Hemoglobin (gm%) | 6.5–16 | 10.6 ± 2.5 | 11.4–16 | 13.3 ± 1.4 | <0.0001*** |
| Platelet count ×103 mm³ | 21–567 | 172.7 ± 104.8 | 168–394 | 282.5 ± 63.5 | <0.0001*** |
| Total leucocytic count/mm³ | 1.2–33 | 8.6 ± 5.6 | 6–15 | 10.0 ± 2.4 | 0.1074* |
| AST (IU/dL) | 11–192 | 41.9 ± 38.0 | 10–38 | 15.7 ± 2.1 | <0.0001*** |
| ALT (IU/dL) | 7–133 | 34.1 ± 29.9 | 12–48 | 18 ± 3.4 | <0.0001*** |
| Bilirubin (mg/dL) | 0.10–2.80 | 0.75 ± 0.64 | 0.1–1.1 | 0.8 ± 0.2 | 0.5992* |
N: number of subjects. *Not significant (NS) (P value > 0.05), **significant (S) (P value < 0.05), ***highly significant (HS) (P value < 0.0001).